Misook Yu

Array ( [id] => 1365380 [patent_doc_number] => 06566084 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'Catalytic antibodies against cocaine and methods of using and producing same' [patent_app_type] => B1 [patent_app_number] => 09/567021 [patent_app_country] => US [patent_app_date] => 2000-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19441 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566084.pdf [firstpage_image] =>[orig_patent_app_number] => 09567021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 626928 [patent_doc_number] => 07135311 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-11-14 [patent_title] => 'Means for detecting and treating pathologies linked to FGFR3' [patent_app_type] => utility [patent_app_number] => 09/959747 [patent_app_country] => US [patent_app_date] => 2000-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 4829 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/135/07135311.pdf [firstpage_image] =>[orig_patent_app_number] => 09959747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1362214 [patent_doc_number] => 06565870 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'Methods for treating bone tumors' [patent_app_type] => B1 [patent_app_number] => 09/561106 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9098 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/565/06565870.pdf [firstpage_image] =>[orig_patent_app_number] => 09561106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 948945 [patent_doc_number] => 06962981 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-11-08 [patent_title] => 'Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen' [patent_app_type] => utility [patent_app_number] => 09/561502 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 25 [patent_no_of_words] => 16316 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/962/06962981.pdf [firstpage_image] =>[orig_patent_app_number] => 09561502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 449160 [patent_doc_number] => 07250488 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-07-31 [patent_title] => 'Transcriptional activation inhibitory protein' [patent_app_type] => utility [patent_app_number] => 09/959474 [patent_app_country] => US [patent_app_date] => 2000-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 20118 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/250/07250488.pdf [firstpage_image] =>[orig_patent_app_number] => 09959474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 744958 [patent_doc_number] => 07026281 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-04-11 [patent_title] => 'Antagonistic analogs of GH-RH inhibiting IGF-I and -II' [patent_app_type] => utility [patent_app_number] => 09/547215 [patent_app_country] => US [patent_app_date] => 2000-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11855 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/026/07026281.pdf [firstpage_image] =>[orig_patent_app_number] => 09547215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 486360 [patent_doc_number] => 07217735 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-05-15 [patent_title] => 'Methods and compositions for enhancing delivery of therapeutic agents to tissues' [patent_app_type] => utility [patent_app_number] => 09/547825 [patent_app_country] => US [patent_app_date] => 2000-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22186 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/217/07217735.pdf [firstpage_image] =>[orig_patent_app_number] => 09547825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1199375 [patent_doc_number] => 06723322 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-20 [patent_title] => 'Angiogenic Onchocerca volvulus proteins and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/541759 [patent_app_country] => US [patent_app_date] => 2000-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10825 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/723/06723322.pdf [firstpage_image] =>[orig_patent_app_number] => 09541759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1275429 [patent_doc_number] => 06649743 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-18 [patent_title] => 'Monoclonal antibody against estrogen stimulated leucine aminopeptidase' [patent_app_type] => B1 [patent_app_number] => 09/538831 [patent_app_country] => US [patent_app_date] => 2000-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8202 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/649/06649743.pdf [firstpage_image] =>[orig_patent_app_number] => 09538831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 676128 [patent_doc_number] => 07087627 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-08 [patent_title] => 'Combinations for the treatment of diseases involving angiogenesis' [patent_app_type] => utility [patent_app_number] => 09/890989 [patent_app_country] => US [patent_app_date] => 2000-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2581 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/087/07087627.pdf [firstpage_image] =>[orig_patent_app_number] => 09890989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 793270 [patent_doc_number] => 06982316 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-01-03 [patent_title] => 'Isolated nucleic acid molecules associated with colon cancer and methods for diagnosing and treating colon cancer' [patent_app_type] => utility [patent_app_number] => 09/502945 [patent_app_country] => US [patent_app_date] => 2000-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3757 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/982/06982316.pdf [firstpage_image] =>[orig_patent_app_number] => 09502945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 648677 [patent_doc_number] => 07115261 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-03 [patent_title] => 'Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies' [patent_app_type] => utility [patent_app_number] => 09/502732 [patent_app_country] => US [patent_app_date] => 2000-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 13410 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/115/07115261.pdf [firstpage_image] =>[orig_patent_app_number] => 09502732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 938494 [patent_doc_number] => 06972323 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-12-06 [patent_title] => 'Anti-Fas antibodies' [patent_app_type] => utility [patent_app_number] => 09/499662 [patent_app_country] => US [patent_app_date] => 2000-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 73 [patent_no_of_words] => 66847 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/972/06972323.pdf [firstpage_image] =>[orig_patent_app_number] => 09499662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 452181 [patent_doc_number] => 07247310 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-07-24 [patent_title] => 'Tumor vaccines' [patent_app_type] => utility [patent_app_number] => 09/890266 [patent_app_country] => US [patent_app_date] => 2000-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 8780 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/247/07247310.pdf [firstpage_image] =>[orig_patent_app_number] => 09890266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1115362 [patent_doc_number] => 06800469 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-05 [patent_title] => 'Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens' [patent_app_type] => B1 [patent_app_number] => 09/490700 [patent_app_country] => US [patent_app_date] => 2000-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 36 [patent_no_of_words] => 22011 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/800/06800469.pdf [firstpage_image] =>[orig_patent_app_number] => 09490700 [rel_patent_id] =>[rel_patent_doc_number] =>)